<div style="position: relative; display: block; max-width: 100%;"><div style="padding-top: 56.25%;"><iframe src="//players.brightcove.net/4365621440001/216a41e4-093d-49b1-831c-dbf5b8ca99d9_default/index.html?videoId=6026852813001" <!-- [et_pb_line_break_holder] -->allowfullscreen <!-- [et_pb_line_break_holder] -->webkitallowfullscreen <!-- [et_pb_line_break_holder] -->mozallowfullscreen <!-- [et_pb_line_break_holder] -->allow="encrypted-media" <!-- [et_pb_line_break_holder] -->style="position: absolute; top: 0px; right: 0px; bottom: 0px; left: 0px; width: 100%; height: 100%;"></iframe></div></div><!-- [et_pb_line_break_holder] -->
Department of Medicine Grand Rounds
April 16, 2019
“Bacteriophage Therapy for Multidrug Resistant Bacterial Infections: Back to the Future“
Joseph Pilewski, MD | Bio
Associate Chief, Division of Pulmonary, Allergy and Critical Care Medicine
Associate Professor of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine
Associate Professor of Cell Biology, Physiology & Pediatrics
Robert Schooley, MD | Bio
Professor of Medicine, Division of Infectious Diseases
Vice Chair, Department of Medicine
Co-Director, Center for Innovative Phage Applications and Therapeutics
Senior Director, International Initiatives
University of California San Diego
